Functional Testing and Non-Drug Supplements Provide Options and Adjuncts to Pharmaceutical Treatments.

Questions to Consider:

• Are most patients you see expressing "mild" or "severe" symptoms of being depressed or anxious?
• Are we getting the entire picture by the pharmaceutical industry and the FDA regarding the effectiveness of SSRIs and SNRIs?
• Given equal efficacy, would you give your patients drugs with "more" side effects or "less"?

A new referenced monograph on this topic authored by R.W. "Chip" Watkins, MD, MPH, FAAFP is now available to help practitioners consider the options. Publication of this paper coincides with a lecture on the topic presented April 30 at the Age Management Medicine Group Spring medical conference in Hollywood, Florida, as well as a live webinar presentation June 2011.
 
In this monograph, Dr Watkins opens with reference to FDA studies that contradict the published pharmaceutical studies regarding effectiveness and potential side effects of the multitude of anti-depressants on the market. With that premise, Dr Watkins goes on to explain key nutraceutical treatment options that have documented effectiveness, and much fewer potential side effects.

Request a copy of this monograph or access to Dr Watkins' lecture recording by calling 866-670-5705 and press "2", Or Click Here for our online request form. Also available is a recommended SSRI Titration Protocol based on the nutraceutical treatment option.

Ask for a Practice Building Specialist to discuss how these protocols may apply to help you address mood disorders, and many other symptoms you see in practice.